Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00790 (
PGA
)
2,475
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rom-1 is a retinal integral membrane protein that, together with the product of the human retinal degeneration slow gene (RDS), defines a photoreceptor-specific protein family. The gene for rom-1 (HGM symbol: ROM1) has been assigned to human chromosome 11 and mouse chromosome 19 by Southern blot analysis of somatic cell hybrid DNAs. ROM1 was regionally sublocalized to human 11p13-11q13 by using three mouse-human somatic cell hybrids; in situ hybridization refined the sublocalization to human 11q13. Analysis of somatic cell hybrids suggested that the most likely localization of ROM1 is in the approximately 2-cM interval between human
PGA
(human
pepsinogen A
) and PYGM (muscle glycogen phosphorylase). ROM1 appears to be a new member of a conserved syntenic group whose members include such genes as CD5, CD20, and OSBP (oxysterol-binding protein), on human chromosome 11 and mouse chromosome 19. Localization of the ROM1 gene will permit the examination of its linkage to hereditary retinopathies in man and mouse.
...
PMID:Localization of the photoreceptor gene ROM1 to human chromosome 11 and mouse chromosome 19: sublocalization to human 11q13 between PGA and PYGM. 141 49
The isozymogens
PGA
-3 and
PGA
-5 of human
pepsinogen A
were digested with endoproteinase Lys-C. The peptides were separated by reverse-phase HPLC.
PGA
-5 showed a peak strongly absorbing at 254 nm absent in
PGA
-3. Analysis of amino acid composition using the Pico-Tag methodology combined with DABITC-sequencing reveals the sequence Tyr-Phe-Pro-Gln-Trp-Lys (peptide 37-43 of the activation segment). This confirms a study at the DNA level by our group [16] suggesting a Glu greater than Lys mutation at position 43 in the activation segment of
PGA
-5. Furthermore, it is proposed that the number of genetic variants of
PGA
is higher than is actually seen by electrophoresis.
...
PMID:Identification of a Glu greater than Lys substitution in the activation segment of human pepsinogen A-3 and -5 isozymogens by peptide mapping using endoproteinase Lys-C. 290 84
To investigate the effect of omeprazole on serum and urinary pepsinogens and on gastric pepsin, 8 healthy male volunteers were studied before and after 9 days of treatment with omeprazole 60 mg/day p.o. Fasting serum samples and 24 h urine specimens were obtained, and gastric contents were aspirated at 15-min intervals, 4 prior to and 6 during pentagastrin 1.5 micrograms.kg-1.h-1 i.v. during intra-gastric perfusion with NaCl 0.9% and phenol red 3 mg.ml-1 as an inert recovery marker. Basal and pentagastrin-stimulated volume and acid secretion were significantly decreased. The basal and pentagastrin stimulated pepsin output remained unchanged but pepsin concentration in gastric secretion was increased. Administration of omeprazole resulted in a significant increase in the serum
PGA
and PGC levels. The 24-h urinary excretion of
PGA
increased, but that of PGC remained unchanged, and so did the renal clearances of creatinine and
pepsinogen A
. The renal clearance of pepsinogen C decreased. It was concluded that omeprazole did not affect gastric pepsin output, but, due to the decreased volume output, the concentration of pepsin in the gastric secretion was increased. Omeprazole increased the serum levels of
pepsinogen A
and C because more pepsinogen was released into the systemic circulation. This might be due to greater back-diffusion of pepsinogen from the gastric mucosa into the systemic circulation as a result of the higher pepsinogen concentration in gastric secretion.
...
PMID:Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man. 314 76
Precursors of the gastric proteases
pepsinogen A
(pepsinogen I) and pepsinogen C (pepsinogen II) and slow-moving protease were demonstrated in biopsy specimens from Barrett's epithelium in 21 of 22 patients with Barrett's esophagus; in 14 of them, in variable combinations at different sites. In 13 of 19 patients (68.4%) with detectable
pepsinogen A
, different isozymogen patterns were found between the Barrett's epithelium and the gastric corpus mucosa. Discrepancies consisted mainly of a stronger
pepsinogen 5
band in the Barrett's epithelium, with a higher incidence in biopsy specimens with features of dysplasia than with no or indefinite dysplasia; the difference was, however, not statistically significant. Zymograms of 69 biopsy specimens from Barrett's epithelium were correlated with the histologic type:
pepsinogen A
and C were most frequently found in the fundic type, least often in the specialized intestinal type. In control gastric corpus biopsy specimens,
pepsinogen A
and C as well as slow-moving protease were always detectable. The observed variability of gastric protease patterns, in particular of
pepsinogen A
isozymograms, may be due to differences in expression within the
pepsinogen A
cluster, suggesting a deregulation of gene expression or partial deletion of the
pepsinogen A
gene cluster.
...
PMID:Gastric proteases in Barrett's esophagus. 330 35
Urinary
pepsinogen A
(
PGA
or PG I) phenotypes and serum
PGA
levels were studied in MZ and DZ twins and their parents. In 45 out of 48 MZ twin pairs
PGA
patterns were completely identical, while 3 MZ twin pairs showed minor differences in the relative intensity of the Pg5 isozymogen. This suggests that the intensity of this isozymogen may be influenced by nongenetic factors. There was little difference in the interclass correlations of serum
PGA
levels between MZ and DZ twins, indicating a large contribution of common environmental factors to serum
PGA
levels. This is in contrast with previous studies.
...
PMID:Twin studies on urinary pepsinogen A phenotypes and serum pepsinogen A levels. 345 14
The determination of serum
pepsinogen A
(= pepsinogen I) levels is of clinical importance in the study of duodenal ulcer, atrophic gastritis and gastric cancer. In the present study two different quantitative immunological techniques for serum
pepsinogen A
were compared: a radioimmunoassay (RIA) (Helsinki) and an enzyme-linked immunosorbent assay (ELISA) (Amsterdam). Serum samples of 177 subjects with various gastric diseases were tested in a double blind study. The correlation was excellent (r = 0.954 in the range 0-760 micrograms/l and r = 0.971 in the range 0-100 micrograms/l). The functional relationship between ELISA (x) and RIA (y), determined by weighted model II regression, was y = 1.12x-0.54. Initially the use of goat anti-
PGA
in the ELISA resulted in falsely high values in about 10% of the individuals. This was caused by circulating antibodies cross-reacting with goat IgG. This artefact was eliminated by pre-incubation of all samples with non-immune goat serum.
...
PMID:Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. 355 88
A 0.9kb cDNA fragment, corresponding to a large part of Rhesus monkey
pepsinogen A
mRNA, was used as probe for the chromosomal localization of the human
pepsinogen A
gene(s) using human-rodent somatic cell hybrids. Southern blot analysis of 14 human-Chinese hamster and three human-mouse cell hybrids, strongly indicates that the human
PGA
locus is on chromosome 11. The human-mouse hybrids, containing a translocation involving chromosome 11, allow sublocalization to the region q12-pter.
...
PMID:Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. 383 86
Serum
pepsinogen A
(pepsinogen I) levels and urinary
pepsinogen A
phenotypes were studied in relation to ABO blood group, age and sex in 700 healthy blood donors. There was no relation between urinary
pepsinogen A
phenotypes and serum
pepsinogen A
levels. It is concluded that serum
PGA
levels and
PGA
phenotypes are independent factors in predisposition to gastroduodenal disorders. Serum
pepsinogen A
levels were higher in males than in females and rose with increasing age. The ABO blood groups were not related to
pepsinogen A
phenotypes. Blood group O individuals showed higher serum
pepsinogen A
levels compared with blood group A. Pepsinogen A phenotypes with intensity of fraction 5 were more frequent in males compared with females.
...
PMID:Relations between serum pepsinogen levels, pepsinogen phenotypes, ABO blood groups, age and sex in blood donors. 406 35
Porcine pepsinogen B was prepared from extracts of adult porcine fundic mucosa. Immunoelectrophoresis showed no immunochemical cross-reactions between pepsinogen B and other porcine gastric zymogens.
Pepsin
B was purified after activation of the zymogen. The enzyme showed an optimum of general proteolytic activity at pH 3.0. Activation of pepsinogen B at pH 2 resulted in formation of the covalent intermediate (pseudo-pepsin B) by proteolytic cleavage of bond Met16p-Glu17p (pig
pepsinogen A
numbering, "p" indicates residues of the prosegment peptide). Pseudopepsin B was stable at pH 2. The intermediate was converted to pepsin B at pH 5.5. The overall activation of pepsinogen B was much slower than found for other investigated gastric zymogens. During the conversion of pepsinogen B to mature pepsin B a segment of 43 amino acid residues was cleaved from the N-terminal of pepsinogen B. The amino acid sequence of the prosegment and the first 24 residues of pepsin B was determined. Relative to porcine
pepsinogen A
, progastricsin, and prochymosin, the following degrees of identities were observed: 40, 55, and 51%.
...
PMID:Purification and characterization of porcine pepsinogen B and pepsin B. 757 16
Peptides from a Staphylococcus aureus (V8) proteinase digest of human pepsin 3b have been identified by amino acid sequence analysis. Only 137 out of 326 expected residues were detected from the C and N terminal regions of the molecule. Comparison with amino acid sequences derived from nucleotide analysis of three different
pepsinogen A
genes, identified 2 out of 4 possible substitutions. The presence of valine at position 30 and leucine at 291 indicates that the major pepsin component of gastric juice, pepsin 3b, corresponds to pepsinogen genotype
PGA
-3. Reversed-phase chromatography of native human pepsin 3b on C4 (300 A), C18 (300 A) or polymer (1000 A) columns was optimal on the C4 column and gradient elution with 2-propanol rather than acetonitrile. Denaturation of the protein in guanidinium hydrochloride, urea or high pH resulted in irreversible column retention. The marked hydrophobicity of denatured pepsin 3b may thus explain why the central segment of the protein was not revealed by peptide map analysis.
...
PMID:Human pepsin 3b peptide map sequence analysis, genotype and hydrophobic nature. 840 29
1
2
Next >>